Friday, September 19, 2014 4:11:40 PM
Yet... Elite has been in constant communication with it's shareholders... every... step... of... the... way. MULTIPLE PRODUCTS! ELI-200, ELI-201, ELI-202...
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=9098999
http://globenewswire.com/news-release/2013/12/05/594970/10060569/en/Elite-Pharmaceuticals-Initiates-Pilot-Bioequivalence-Study-for-ELI-201.html
http://www.marketwatch.com/story/elite-pharmaceuticals-initiates-pivotal-bioequivalence-study-for-second-opioid-abuse-deterrent-product-2014-01-14?reflink=MW_news_stmp
http://globenewswire.com/news-release/2014/03/05/615789/10071309/en/Elite-Pharmaceuticals-Reports-Successful-Pivotal-Bioequivalence-Study-for-Abuse-Deterrent-Product-ELI-200.html
http://www.elitepharma.com/investor_relations.asp?goto=384
http://www.marketwatch.com/story/elite-pharmaceuticals-begins-human-abuse-liability-studies-for-eli-200-2014-06-09
http://www.marketwatch.com/story/elite-pharmaceuticals-initiates-pivotal-bioequivalence-study-for-eli-201-2014-07-15
http://www.elitepharma.com/investor_relations.asp?goto=387
Can I get a WHAT, WHAT??? (raising hands in the air, like I just don't care).
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM